In this ‘Ask the experts’ feature, a panel of key thought leaders share their perspectives on current obstacles and future developments in scale-up and process development. For example, at what point should you start to consider scaling your process, and what questions do you need to have answered? Would it be better to scale-up or scale-out your process, and how can external partners support you?
- Steven Thompson (Sexton Biotechnologies, IN, USA)
- Hetal Brahmbhatt (Thermo Fisher Scientific, MD, USA)
- Paul Carter (Quell Therapeutics Ltd, London, UK)
- Carl A. Gregory and Roland Kaunas (Texas A&M University, TX, USA)